nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC16A1—Methotrexate—muscle cancer	0.123	0.203	CbGbCtD
Valproic Acid—SLC22A5—Dactinomycin—muscle cancer	0.121	0.2	CbGbCtD
Valproic Acid—SLC22A7—Methotrexate—muscle cancer	0.0606	0.0999	CbGbCtD
Valproic Acid—PTGS1—Etoposide—muscle cancer	0.0445	0.0734	CbGbCtD
Valproic Acid—CYP1A2—Dacarbazine—muscle cancer	0.0406	0.067	CbGbCtD
Valproic Acid—SLC22A8—Methotrexate—muscle cancer	0.037	0.061	CbGbCtD
Valproic Acid—CYP3A5—Vincristine—muscle cancer	0.0291	0.048	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—muscle cancer	0.0267	0.044	CbGbCtD
Valproic Acid—SLC22A6—Methotrexate—muscle cancer	0.0258	0.0425	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—muscle cancer	0.0257	0.0423	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—muscle cancer	0.0231	0.0381	CbGbCtD
Valproic Acid—CYP1A2—Etoposide—muscle cancer	0.0199	0.0328	CbGbCtD
Valproic Acid—OGDH—TCA Cycle and PDHc—FH—muscle cancer	0.0173	0.152	CbGpPWpGaD
Valproic Acid—OGDH—TCA Cycle—FH—muscle cancer	0.0165	0.145	CbGpPWpGaD
Valproic Acid—OGDH—Citric acid cycle (TCA cycle)—FH—muscle cancer	0.0151	0.132	CbGpPWpGaD
Valproic Acid—CYP3A4—Vincristine—muscle cancer	0.0114	0.0187	CbGbCtD
Valproic Acid—CYP3A4—Etoposide—muscle cancer	0.0104	0.0172	CbGbCtD
Valproic Acid—OGDH—Pyruvate metabolism and Citric Acid (TCA) cycle—FH—muscle cancer	0.00755	0.0663	CbGpPWpGaD
Valproic Acid—CYP3A4—Doxorubicin—muscle cancer	0.0071	0.0117	CbGbCtD
Valproic Acid—ALDH5A1—Vinblastine—Vincristine—muscle cancer	0.00432	0.723	CbGdCrCtD
Valproic Acid—UGT1A10—renal system—muscle cancer	0.00395	0.0396	CbGeAlD
Valproic Acid—HDAC9—Neural Crest Differentiation—PAX7—muscle cancer	0.00341	0.03	CbGpPWpGaD
Valproic Acid—UGT1A8—renal system—muscle cancer	0.00313	0.0313	CbGeAlD
Valproic Acid—OGDH—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00293	0.0257	CbGpPWpGaD
Valproic Acid—OGDH—renal system—muscle cancer	0.00291	0.0291	CbGeAlD
Valproic Acid—HDAC9—Neural Crest Differentiation—PAX3—muscle cancer	0.0029	0.0255	CbGpPWpGaD
Valproic Acid—OGDH—cardiac atrium—muscle cancer	0.0026	0.0261	CbGeAlD
Valproic Acid—UGT1A6—testis—muscle cancer	0.00238	0.0238	CbGeAlD
Valproic Acid—UGT1A4—renal system—muscle cancer	0.00237	0.0237	CbGeAlD
Valproic Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—FH—muscle cancer	0.00234	0.0206	CbGpPWpGaD
Valproic Acid—ACADSB—renal system—muscle cancer	0.00231	0.0231	CbGeAlD
Valproic Acid—OGDH—tendon—muscle cancer	0.00227	0.0227	CbGeAlD
Valproic Acid—OGDH—bone marrow—muscle cancer	0.0022	0.022	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYF5—muscle cancer	0.0021	0.0184	CbGpPWpGaD
Valproic Acid—UGT1A8—head—muscle cancer	0.00209	0.0209	CbGeAlD
Valproic Acid—ACADSB—cardiac atrium—muscle cancer	0.00207	0.0207	CbGeAlD
Valproic Acid—ALDH5A1—renal system—muscle cancer	0.00203	0.0204	CbGeAlD
Valproic Acid—HDAC9—tendon—muscle cancer	0.002	0.02	CbGeAlD
Valproic Acid—UGT1A9—renal system—muscle cancer	0.00199	0.0199	CbGeAlD
Valproic Acid—OGDH—head—muscle cancer	0.00194	0.0195	CbGeAlD
Valproic Acid—HDAC9—bone marrow—muscle cancer	0.00194	0.0194	CbGeAlD
Valproic Acid—OGDH—testis—muscle cancer	0.00188	0.0188	CbGeAlD
Valproic Acid—ALDH5A1—cardiac atrium—muscle cancer	0.00182	0.0182	CbGeAlD
Valproic Acid—ACADSB—tendon—muscle cancer	0.0018	0.018	CbGeAlD
Valproic Acid—ACADSB—bone marrow—muscle cancer	0.00175	0.0175	CbGeAlD
Valproic Acid—ABAT—renal system—muscle cancer	0.00174	0.0174	CbGeAlD
Valproic Acid—HDAC2—embryo—muscle cancer	0.00173	0.0173	CbGeAlD
Valproic Acid—HDAC9—head—muscle cancer	0.00171	0.0172	CbGeAlD
Valproic Acid—ACADSB—vagina—muscle cancer	0.00167	0.0167	CbGeAlD
Valproic Acid—HDAC9—testis—muscle cancer	0.00166	0.0166	CbGeAlD
Valproic Acid—HDAC2—Teniposide—Etoposide—muscle cancer	0.00165	0.277	CbGdCrCtD
Valproic Acid—UGT2B7—renal system—muscle cancer	0.0016	0.016	CbGeAlD
Valproic Acid—ALDH5A1—tendon—muscle cancer	0.00159	0.0159	CbGeAlD
Valproic Acid—ALDH5A1—bone marrow—muscle cancer	0.00154	0.0154	CbGeAlD
Valproic Acid—SLC22A7—renal system—muscle cancer	0.00152	0.0152	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	0.0015	0.0132	CbGpPWpGaD
Valproic Acid—ACADSB—testis—muscle cancer	0.00149	0.0149	CbGeAlD
Valproic Acid—HDAC2—Neural Crest Differentiation—PAX7—muscle cancer	0.00148	0.013	CbGpPWpGaD
Valproic Acid—ALDH5A1—vagina—muscle cancer	0.00147	0.0147	CbGeAlD
Valproic Acid—UGT1A6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.00139	0.0122	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00138	0.0122	CbGpPWpGaD
Valproic Acid—OGDH—Tryptophan metabolism—MDM2—muscle cancer	0.00138	0.0121	CbGpPWpGaD
Valproic Acid—HDAC2—smooth muscle tissue—muscle cancer	0.00136	0.0136	CbGeAlD
Valproic Acid—ALDH5A1—head—muscle cancer	0.00136	0.0136	CbGeAlD
Valproic Acid—ABAT—tendon—muscle cancer	0.00136	0.0136	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—muscle cancer	0.00135	0.0119	CbGpPWpGaD
Valproic Acid—ALDH5A1—testis—muscle cancer	0.00131	0.0132	CbGeAlD
Valproic Acid—HDAC2—renal system—muscle cancer	0.00131	0.0131	CbGeAlD
Valproic Acid—ABAT—vagina—muscle cancer	0.00126	0.0126	CbGeAlD
Valproic Acid—HDAC2—Neural Crest Differentiation—PAX3—muscle cancer	0.00126	0.0111	CbGpPWpGaD
Valproic Acid—CYP2C18—vagina—muscle cancer	0.00126	0.0126	CbGeAlD
Valproic Acid—SLC16A1—renal system—muscle cancer	0.00116	0.0117	CbGeAlD
Valproic Acid—ABAT—head—muscle cancer	0.00116	0.0117	CbGeAlD
Valproic Acid—ABAT—testis—muscle cancer	0.00112	0.0113	CbGeAlD
Valproic Acid—UGT1A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.00107	0.0094	CbGpPWpGaD
Valproic Acid—SLC16A1—cardiac atrium—muscle cancer	0.00104	0.0104	CbGeAlD
Valproic Acid—UGT2B7—testis—muscle cancer	0.00103	0.0104	CbGeAlD
Valproic Acid—HDAC2—tendon—muscle cancer	0.00102	0.0102	CbGeAlD
Valproic Acid—HDAC2—Hedgehog signaling events mediated by Gli proteins—PTCH1—muscle cancer	0.000994	0.00873	CbGpPWpGaD
Valproic Acid—HDAC2—bone marrow—muscle cancer	0.00099	0.00992	CbGeAlD
Valproic Acid—SLC22A7—testis—muscle cancer	0.000984	0.00985	CbGeAlD
Valproic Acid—HDAC2—vagina—muscle cancer	0.000949	0.0095	CbGeAlD
Valproic Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.000909	0.00798	CbGpPWpGaD
Valproic Acid—SLC16A1—tendon—muscle cancer	0.000909	0.0091	CbGeAlD
Valproic Acid—UGT1A3—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.00089	0.00782	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—WT1—muscle cancer	0.000884	0.00777	CbGpPWpGaD
Valproic Acid—SLC22A8—renal system—muscle cancer	0.00088	0.00881	CbGeAlD
Valproic Acid—HDAC2—head—muscle cancer	0.000876	0.00878	CbGeAlD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—ANGPT2—muscle cancer	0.000864	0.00759	CbGpPWpGaD
Valproic Acid—HDAC2—testis—muscle cancer	0.000847	0.00848	CbGeAlD
Valproic Acid—CYP2A6—vagina—muscle cancer	0.000831	0.00832	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	0.000827	0.00726	CbGpPWpGaD
Valproic Acid—SLC16A1—head—muscle cancer	0.000779	0.0078	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—muscle cancer	0.000764	0.00671	CbGpPWpGaD
Valproic Acid—SLC16A1—testis—muscle cancer	0.000752	0.00753	CbGeAlD
Valproic Acid—HDAC2—Direct p53 effectors—PMS2—muscle cancer	0.000704	0.00619	CbGpPWpGaD
Valproic Acid—SLC22A5—renal system—muscle cancer	0.000665	0.00666	CbGeAlD
Valproic Acid—HDAC2—Direct p53 effectors—TP73—muscle cancer	0.000655	0.00575	CbGpPWpGaD
Valproic Acid—CYP2C8—renal system—muscle cancer	0.000644	0.00645	CbGeAlD
Valproic Acid—UGT1A9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000615	0.0054	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—KIDINS220—muscle cancer	0.000605	0.00532	CbGpPWpGaD
Valproic Acid—CYP1A2—renal system—muscle cancer	0.000602	0.00603	CbGeAlD
Valproic Acid—SLC22A5—cardiac atrium—muscle cancer	0.000596	0.00596	CbGeAlD
Valproic Acid—SLC22A8—head—muscle cancer	0.000589	0.0059	CbGeAlD
Valproic Acid—CYP3A5—renal system—muscle cancer	0.000581	0.00582	CbGeAlD
Valproic Acid—CYP2B6—renal system—muscle cancer	0.000577	0.00578	CbGeAlD
Valproic Acid—HDAC2—Direct p53 effectors—TP63—muscle cancer	0.000563	0.00495	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	0.000562	0.00494	CbGpPWpGaD
Valproic Acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—muscle cancer	0.000562	0.00493	CbGpPWpGaD
Valproic Acid—PTGS1—smooth muscle tissue—muscle cancer	0.000542	0.00543	CbGeAlD
Valproic Acid—CYP2C19—vagina—muscle cancer	0.000534	0.00535	CbGeAlD
Valproic Acid—PTGS1—renal system—muscle cancer	0.000522	0.00523	CbGeAlD
Valproic Acid—ACADSB—Metabolism—FH—muscle cancer	0.00052	0.00456	CbGpPWpGaD
Valproic Acid—SLC22A5—tendon—muscle cancer	0.000519	0.0052	CbGeAlD
Valproic Acid—SLC22A5—vagina—muscle cancer	0.000482	0.00482	CbGeAlD
Valproic Acid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	0.000477	0.00419	CbGpPWpGaD
Valproic Acid—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000474	0.00416	CbGpPWpGaD
Valproic Acid—PTGS1—cardiac atrium—muscle cancer	0.000468	0.00468	CbGeAlD
Valproic Acid—HDAC2—Cell Cycle—BUB1B—muscle cancer	0.000467	0.00411	CbGpPWpGaD
Valproic Acid—CYP2C8—vagina—muscle cancer	0.000466	0.00467	CbGeAlD
Valproic Acid—OGDH—Metabolism—FH—muscle cancer	0.000442	0.00388	CbGpPWpGaD
Valproic Acid—PTGS1—Overview of nanoparticle effects—PTGS2—muscle cancer	0.00044	0.00387	CbGpPWpGaD
Valproic Acid—CYP3A4—renal system—muscle cancer	0.000436	0.00437	CbGeAlD
Valproic Acid—SLC22A5—testis—muscle cancer	0.00043	0.0043	CbGeAlD
Valproic Acid—CYP3A5—vagina—muscle cancer	0.000421	0.00422	CbGeAlD
Valproic Acid—CYP2B6—vagina—muscle cancer	0.000418	0.00419	CbGeAlD
Valproic Acid—UGT1A9—PPARA activates gene expression—MED12—muscle cancer	0.000417	0.00366	CbGpPWpGaD
Valproic Acid—CYP2C8—testis—muscle cancer	0.000416	0.00417	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	0.000415	0.00365	CbGpPWpGaD
Valproic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.000408	0.00359	CbGpPWpGaD
Valproic Acid—PTGS1—tendon—muscle cancer	0.000408	0.00408	CbGeAlD
Valproic Acid—CYP2B6—head—muscle cancer	0.000386	0.00387	CbGeAlD
Valproic Acid—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000382	0.00336	CbGpPWpGaD
Valproic Acid—PTGS1—vagina—muscle cancer	0.000378	0.00379	CbGeAlD
Valproic Acid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	0.000376	0.0033	CbGpPWpGaD
Valproic Acid—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000374	0.00328	CbGpPWpGaD
Valproic Acid—CYP2B6—testis—muscle cancer	0.000373	0.00374	CbGeAlD
Valproic Acid—PTGS1—Eicosanoid Synthesis—PTGS2—muscle cancer	0.000365	0.00321	CbGpPWpGaD
Valproic Acid—PTGS1—head—muscle cancer	0.000349	0.0035	CbGeAlD
Valproic Acid—CYP2C18—Tryptophan metabolism—MDM2—muscle cancer	0.000349	0.00307	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000347	0.00305	CbGpPWpGaD
Valproic Acid—PTGS1—testis—muscle cancer	0.000337	0.00338	CbGeAlD
Valproic Acid—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000313	0.00275	CbGpPWpGaD
Valproic Acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	0.000305	0.00268	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KIDINS220—muscle cancer	0.0003	0.00263	CbGpPWpGaD
Valproic Acid—SLC22A7—Fluoropyrimidine Activity—TP53—muscle cancer	0.000297	0.00261	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—MED12—muscle cancer	0.000294	0.00258	CbGpPWpGaD
Valproic Acid—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000289	0.00254	CbGpPWpGaD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.000281	0.00247	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—FH—muscle cancer	0.000273	0.0024	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—ENO2—muscle cancer	0.000268	0.00235	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—MDM2—muscle cancer	0.000266	0.00234	CbGpPWpGaD
Valproic Acid—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000264	0.00231	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000263	0.00231	CbGpPWpGaD
Valproic Acid—Eosinophilia—Methotrexate—muscle cancer	0.000263	0.00151	CcSEcCtD
Valproic Acid—Affect lability—Doxorubicin—muscle cancer	0.000262	0.0015	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000261	0.0015	CcSEcCtD
Valproic Acid—Pancreatitis—Methotrexate—muscle cancer	0.00026	0.00149	CcSEcCtD
Valproic Acid—HDAC9—Signaling by NOTCH—TP53—muscle cancer	0.00026	0.00228	CbGpPWpGaD
Valproic Acid—Discomfort—Etoposide—muscle cancer	0.00026	0.00149	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.000259	0.00228	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000258	0.00227	CbGpPWpGaD
Valproic Acid—Face oedema—Doxorubicin—muscle cancer	0.000257	0.00147	CcSEcCtD
Valproic Acid—Hypersensitivity—Dactinomycin—muscle cancer	0.000256	0.00147	CcSEcCtD
Valproic Acid—Abdominal discomfort—Methotrexate—muscle cancer	0.000254	0.00146	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Vincristine—muscle cancer	0.000254	0.00146	CcSEcCtD
Valproic Acid—Confusional state—Etoposide—muscle cancer	0.000254	0.00146	CcSEcCtD
Valproic Acid—Pancytopenia—Methotrexate—muscle cancer	0.000252	0.00144	CcSEcCtD
Valproic Acid—Anaphylactic shock—Etoposide—muscle cancer	0.000252	0.00144	CcSEcCtD
Valproic Acid—Mood swings—Doxorubicin—muscle cancer	0.000252	0.00144	CcSEcCtD
Valproic Acid—Infection—Etoposide—muscle cancer	0.00025	0.00143	CcSEcCtD
Valproic Acid—Ataxia—Doxorubicin—muscle cancer	0.00025	0.00143	CcSEcCtD
Valproic Acid—OGDH—Metabolism—MED12—muscle cancer	0.00025	0.00219	CbGpPWpGaD
Valproic Acid—Asthenia—Dactinomycin—muscle cancer	0.00025	0.00143	CcSEcCtD
Valproic Acid—Neutropenia—Methotrexate—muscle cancer	0.000248	0.00142	CcSEcCtD
Valproic Acid—Dysuria—Methotrexate—muscle cancer	0.000248	0.00142	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.000247	0.00217	CbGpPWpGaD
Valproic Acid—Thrombocytopenia—Etoposide—muscle cancer	0.000247	0.00141	CcSEcCtD
Valproic Acid—Tachycardia—Etoposide—muscle cancer	0.000246	0.00141	CcSEcCtD
Valproic Acid—Abdominal pain—Vincristine—muscle cancer	0.000246	0.00141	CcSEcCtD
Valproic Acid—Body temperature increased—Vincristine—muscle cancer	0.000246	0.00141	CcSEcCtD
Valproic Acid—Skin disorder—Etoposide—muscle cancer	0.000245	0.0014	CcSEcCtD
Valproic Acid—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000244	0.00214	CbGpPWpGaD
Valproic Acid—Dry skin—Doxorubicin—muscle cancer	0.000244	0.0014	CcSEcCtD
Valproic Acid—Hyperhidrosis—Etoposide—muscle cancer	0.000243	0.0014	CcSEcCtD
Valproic Acid—Abdominal pain upper—Doxorubicin—muscle cancer	0.000243	0.00139	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000243	0.00139	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Methotrexate—muscle cancer	0.000242	0.00139	CcSEcCtD
Valproic Acid—Breast disorder—Doxorubicin—muscle cancer	0.00024	0.00138	CcSEcCtD
Valproic Acid—Anorexia—Etoposide—muscle cancer	0.00024	0.00138	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000239	0.00137	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000239	0.00137	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—FH—muscle cancer	0.000239	0.0021	CbGpPWpGaD
Valproic Acid—Diarrhoea—Dactinomycin—muscle cancer	0.000238	0.00136	CcSEcCtD
Valproic Acid—Pneumonia—Methotrexate—muscle cancer	0.000238	0.00136	CcSEcCtD
Valproic Acid—Drowsiness—Methotrexate—muscle cancer	0.000236	0.00136	CcSEcCtD
Valproic Acid—Depression—Methotrexate—muscle cancer	0.000236	0.00135	CcSEcCtD
Valproic Acid—Hypotension—Etoposide—muscle cancer	0.000235	0.00135	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000234	0.00134	CcSEcCtD
Valproic Acid—Muscular weakness—Doxorubicin—muscle cancer	0.000234	0.00134	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000234	0.00134	CcSEcCtD
Valproic Acid—SLC16A1—Hemostasis—ANGPT2—muscle cancer	0.000234	0.00206	CbGpPWpGaD
Valproic Acid—Stomatitis—Methotrexate—muscle cancer	0.00023	0.00132	CcSEcCtD
Valproic Acid—Conjunctivitis—Methotrexate—muscle cancer	0.00023	0.00132	CcSEcCtD
Valproic Acid—Influenza—Doxorubicin—muscle cancer	0.00023	0.00132	CcSEcCtD
Valproic Acid—Dysphagia—Doxorubicin—muscle cancer	0.00023	0.00132	CcSEcCtD
Valproic Acid—Hypersensitivity—Vincristine—muscle cancer	0.000229	0.00131	CcSEcCtD
Valproic Acid—OGDH—Metabolism—ENO2—muscle cancer	0.000228	0.002	CbGpPWpGaD
Valproic Acid—Eosinophilia—Doxorubicin—muscle cancer	0.000227	0.0013	CcSEcCtD
Valproic Acid—Sweating—Methotrexate—muscle cancer	0.000227	0.0013	CcSEcCtD
Valproic Acid—Paraesthesia—Etoposide—muscle cancer	0.000226	0.0013	CcSEcCtD
Valproic Acid—Pancreatitis—Doxorubicin—muscle cancer	0.000225	0.00129	CcSEcCtD
Valproic Acid—Dyspnoea—Etoposide—muscle cancer	0.000224	0.00129	CcSEcCtD
Valproic Acid—Somnolence—Etoposide—muscle cancer	0.000224	0.00128	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Methotrexate—muscle cancer	0.000224	0.00128	CcSEcCtD
Valproic Acid—Epistaxis—Methotrexate—muscle cancer	0.000223	0.00128	CcSEcCtD
Valproic Acid—Asthenia—Vincristine—muscle cancer	0.000223	0.00128	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—muscle cancer	0.000221	0.00127	CcSEcCtD
Valproic Acid—Bronchitis—Doxorubicin—muscle cancer	0.000221	0.00127	CcSEcCtD
Valproic Acid—Agranulocytosis—Methotrexate—muscle cancer	0.000221	0.00127	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—muscle cancer	0.000219	0.00126	CcSEcCtD
Valproic Acid—Decreased appetite—Etoposide—muscle cancer	0.000219	0.00126	CcSEcCtD
Valproic Acid—Pancytopenia—Doxorubicin—muscle cancer	0.000218	0.00125	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Etoposide—muscle cancer	0.000217	0.00125	CcSEcCtD
Valproic Acid—Fatigue—Etoposide—muscle cancer	0.000217	0.00124	CcSEcCtD
Valproic Acid—Pain—Etoposide—muscle cancer	0.000215	0.00123	CcSEcCtD
Valproic Acid—Constipation—Etoposide—muscle cancer	0.000215	0.00123	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—muscle cancer	0.000215	0.00123	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—muscle cancer	0.000215	0.00123	CcSEcCtD
Valproic Acid—HDAC2—Hemostasis—ANGPT2—muscle cancer	0.000214	0.00188	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—CDKN2A—muscle cancer	0.000214	0.00188	CbGpPWpGaD
Valproic Acid—Haemoglobin—Methotrexate—muscle cancer	0.000213	0.00122	CcSEcCtD
Valproic Acid—Diarrhoea—Vincristine—muscle cancer	0.000213	0.00122	CcSEcCtD
Valproic Acid—Haemorrhage—Methotrexate—muscle cancer	0.000212	0.00122	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—muscle cancer	0.000212	0.00122	CcSEcCtD
Valproic Acid—Pharyngitis—Methotrexate—muscle cancer	0.000211	0.00121	CcSEcCtD
Valproic Acid—Urinary tract disorder—Methotrexate—muscle cancer	0.00021	0.0012	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00021	0.0012	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—muscle cancer	0.000209	0.0012	CcSEcCtD
Valproic Acid—Urethral disorder—Methotrexate—muscle cancer	0.000208	0.00119	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—muscle cancer	0.000208	0.00119	CcSEcCtD
Valproic Acid—Feeling abnormal—Etoposide—muscle cancer	0.000207	0.00119	CcSEcCtD
Valproic Acid—HDAC2—Cell Cycle—MDM2—muscle cancer	0.000207	0.00182	CbGpPWpGaD
Valproic Acid—Nausea—Dactinomycin—muscle cancer	0.000207	0.00118	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—muscle cancer	0.000206	0.00118	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Etoposide—muscle cancer	0.000206	0.00118	CcSEcCtD
Valproic Acid—Dizziness—Vincristine—muscle cancer	0.000206	0.00118	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—FOXO4—muscle cancer	0.000205	0.0018	CbGpPWpGaD
Valproic Acid—Drowsiness—Doxorubicin—muscle cancer	0.000205	0.00117	CcSEcCtD
Valproic Acid—Visual impairment—Methotrexate—muscle cancer	0.000205	0.00117	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000203	0.00116	CcSEcCtD
Valproic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000203	0.00178	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—MDM2—muscle cancer	0.000202	0.00177	CbGpPWpGaD
Valproic Acid—Erythema multiforme—Methotrexate—muscle cancer	0.000201	0.00115	CcSEcCtD
Valproic Acid—Urticaria—Etoposide—muscle cancer	0.0002	0.00115	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—muscle cancer	0.0002	0.00114	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—FH—muscle cancer	0.000199	0.00175	CbGpPWpGaD
Valproic Acid—Abdominal pain—Etoposide—muscle cancer	0.000199	0.00114	CcSEcCtD
Valproic Acid—Body temperature increased—Etoposide—muscle cancer	0.000199	0.00114	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—muscle cancer	0.000199	0.00114	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—muscle cancer	0.000199	0.00114	CcSEcCtD
Valproic Acid—Eye disorder—Methotrexate—muscle cancer	0.000198	0.00114	CcSEcCtD
Valproic Acid—Tinnitus—Methotrexate—muscle cancer	0.000198	0.00113	CcSEcCtD
Valproic Acid—Vomiting—Vincristine—muscle cancer	0.000198	0.00113	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—muscle cancer	0.000196	0.00113	CcSEcCtD
Valproic Acid—Rash—Vincristine—muscle cancer	0.000196	0.00112	CcSEcCtD
Valproic Acid—Dermatitis—Vincristine—muscle cancer	0.000196	0.00112	CcSEcCtD
Valproic Acid—Headache—Vincristine—muscle cancer	0.000195	0.00112	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000194	0.00111	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—muscle cancer	0.000193	0.00111	CcSEcCtD
Valproic Acid—Angiopathy—Methotrexate—muscle cancer	0.000193	0.0011	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—muscle cancer	0.000192	0.0011	CcSEcCtD
Valproic Acid—Immune system disorder—Methotrexate—muscle cancer	0.000192	0.0011	CcSEcCtD
Valproic Acid—Mediastinal disorder—Methotrexate—muscle cancer	0.000191	0.0011	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—muscle cancer	0.000191	0.0011	CcSEcCtD
Valproic Acid—Chills—Methotrexate—muscle cancer	0.00019	0.00109	CcSEcCtD
Valproic Acid—Alopecia—Methotrexate—muscle cancer	0.000188	0.00108	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—muscle cancer	0.000187	0.00107	CcSEcCtD
Valproic Acid—Mental disorder—Methotrexate—muscle cancer	0.000186	0.00107	CcSEcCtD
Valproic Acid—Hypersensitivity—Etoposide—muscle cancer	0.000186	0.00106	CcSEcCtD
Valproic Acid—Malnutrition—Methotrexate—muscle cancer	0.000185	0.00106	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—muscle cancer	0.000185	0.00106	CcSEcCtD
Valproic Acid—Nausea—Vincristine—muscle cancer	0.000185	0.00106	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—muscle cancer	0.000184	0.00106	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—muscle cancer	0.000184	0.00105	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—muscle cancer	0.000183	0.00105	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—muscle cancer	0.000182	0.00105	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—muscle cancer	0.000182	0.00104	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—muscle cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Dysgeusia—Methotrexate—muscle cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Asthenia—Etoposide—muscle cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—muscle cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—muscle cancer	0.00018	0.00103	CcSEcCtD
Valproic Acid—Back pain—Methotrexate—muscle cancer	0.000179	0.00102	CcSEcCtD
Valproic Acid—Pruritus—Etoposide—muscle cancer	0.000178	0.00102	CcSEcCtD
Valproic Acid—HDAC9—Disease—ENO2—muscle cancer	0.000178	0.00156	CbGpPWpGaD
Valproic Acid—Visual impairment—Doxorubicin—muscle cancer	0.000177	0.00102	CcSEcCtD
Valproic Acid—Vision blurred—Methotrexate—muscle cancer	0.000174	0.000999	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—muscle cancer	0.000174	0.000997	CcSEcCtD
Valproic Acid—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000174	0.00153	CbGpPWpGaD
Valproic Acid—Diarrhoea—Etoposide—muscle cancer	0.000172	0.000988	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—muscle cancer	0.000172	0.000985	CcSEcCtD
Valproic Acid—Ill-defined disorder—Methotrexate—muscle cancer	0.000171	0.000983	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—muscle cancer	0.000171	0.000983	CcSEcCtD
Valproic Acid—Anaemia—Methotrexate—muscle cancer	0.000171	0.000979	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—muscle cancer	0.000167	0.000956	CcSEcCtD
Valproic Acid—Malaise—Methotrexate—muscle cancer	0.000167	0.000956	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—muscle cancer	0.000167	0.000955	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—muscle cancer	0.000166	0.000952	CcSEcCtD
Valproic Acid—Vertigo—Methotrexate—muscle cancer	0.000166	0.000952	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—muscle cancer	0.000166	0.00095	CcSEcCtD
Valproic Acid—Leukopenia—Methotrexate—muscle cancer	0.000165	0.000948	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—muscle cancer	0.000165	0.000946	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—muscle cancer	0.000164	0.000942	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—muscle cancer	0.000162	0.000931	CcSEcCtD
Valproic Acid—HDAC9—Disease—HMGA1—muscle cancer	0.000162	0.00142	CbGpPWpGaD
Valproic Acid—Cough—Methotrexate—muscle cancer	0.000161	0.000925	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—muscle cancer	0.000161	0.000923	CcSEcCtD
Valproic Acid—HDAC2—Direct p53 effectors—MDM2—muscle cancer	0.000161	0.00141	CbGpPWpGaD
Valproic Acid—Vomiting—Etoposide—muscle cancer	0.00016	0.000918	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—muscle cancer	0.00016	0.000918	CcSEcCtD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—muscle cancer	0.000159	0.0014	CbGpPWpGaD
Valproic Acid—Rash—Etoposide—muscle cancer	0.000159	0.00091	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—muscle cancer	0.000159	0.000909	CcSEcCtD
Valproic Acid—Headache—Etoposide—muscle cancer	0.000158	0.000904	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—muscle cancer	0.000158	0.000904	CcSEcCtD
Valproic Acid—Chest pain—Methotrexate—muscle cancer	0.000157	0.000902	CcSEcCtD
Valproic Acid—Myalgia—Methotrexate—muscle cancer	0.000157	0.000902	CcSEcCtD
Valproic Acid—Arthralgia—Methotrexate—muscle cancer	0.000157	0.000902	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—muscle cancer	0.000157	0.0009	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—muscle cancer	0.000157	0.000898	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000156	0.000896	CcSEcCtD
Valproic Acid—Discomfort—Methotrexate—muscle cancer	0.000155	0.000891	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—muscle cancer	0.000155	0.000891	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—muscle cancer	0.000155	0.000888	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—MED12—muscle cancer	0.000154	0.00135	CbGpPWpGaD
Valproic Acid—Muscle spasms—Doxorubicin—muscle cancer	0.000154	0.000882	CcSEcCtD
Valproic Acid—UGT1A4—Metabolism—FH—muscle cancer	0.000154	0.00135	CbGpPWpGaD
Valproic Acid—Confusional state—Methotrexate—muscle cancer	0.000152	0.000872	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—FOXO1—muscle cancer	0.000151	0.00133	CbGpPWpGaD
Valproic Acid—Anaphylactic shock—Methotrexate—muscle cancer	0.000151	0.000865	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—muscle cancer	0.000151	0.000865	CcSEcCtD
Valproic Acid—Infection—Methotrexate—muscle cancer	0.00015	0.000859	CcSEcCtD
Valproic Acid—Nausea—Etoposide—muscle cancer	0.00015	0.000858	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—muscle cancer	0.000148	0.000851	CcSEcCtD
Valproic Acid—Nervous system disorder—Methotrexate—muscle cancer	0.000148	0.000848	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—muscle cancer	0.000148	0.000848	CcSEcCtD
Valproic Acid—Thrombocytopenia—Methotrexate—muscle cancer	0.000148	0.000847	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—muscle cancer	0.000147	0.000843	CcSEcCtD
Valproic Acid—Skin disorder—Methotrexate—muscle cancer	0.000146	0.00084	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methotrexate—muscle cancer	0.000146	0.000836	CcSEcCtD
Valproic Acid—HDAC9—Disease—FOXO4—muscle cancer	0.000145	0.00127	CbGpPWpGaD
Valproic Acid—Malaise—Doxorubicin—muscle cancer	0.000144	0.000827	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—muscle cancer	0.000144	0.000824	CcSEcCtD
Valproic Acid—Anorexia—Methotrexate—muscle cancer	0.000144	0.000824	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—muscle cancer	0.000143	0.000821	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000142	0.00124	CbGpPWpGaD
Valproic Acid—Palpitations—Doxorubicin—muscle cancer	0.000141	0.000811	CcSEcCtD
Valproic Acid—Hypotension—Methotrexate—muscle cancer	0.000141	0.000808	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—ENO2—muscle cancer	0.000141	0.00124	CbGpPWpGaD
Valproic Acid—Cough—Doxorubicin—muscle cancer	0.00014	0.000801	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—muscle cancer	0.000138	0.000792	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000137	0.000788	CcSEcCtD
Valproic Acid—SLC16A1—Metabolism—FH—muscle cancer	0.000137	0.0012	CbGpPWpGaD
Valproic Acid—Insomnia—Methotrexate—muscle cancer	0.000136	0.000782	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—muscle cancer	0.000136	0.000781	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—muscle cancer	0.000136	0.000781	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—muscle cancer	0.000136	0.000781	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—muscle cancer	0.000136	0.000778	CcSEcCtD
Valproic Acid—Paraesthesia—Methotrexate—muscle cancer	0.000135	0.000777	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000135	0.000776	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—MED12—muscle cancer	0.000135	0.00118	CbGpPWpGaD
Valproic Acid—Discomfort—Doxorubicin—muscle cancer	0.000135	0.000772	CcSEcCtD
Valproic Acid—Dyspnoea—Methotrexate—muscle cancer	0.000134	0.000771	CcSEcCtD
Valproic Acid—Somnolence—Methotrexate—muscle cancer	0.000134	0.000769	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—muscle cancer	0.000133	0.000764	CcSEcCtD
Valproic Acid—Dyspepsia—Methotrexate—muscle cancer	0.000133	0.000761	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—muscle cancer	0.000132	0.000755	CcSEcCtD
Valproic Acid—Decreased appetite—Methotrexate—muscle cancer	0.000131	0.000752	CcSEcCtD
Valproic Acid—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000131	0.00115	CbGpPWpGaD
Valproic Acid—Anaphylactic shock—Doxorubicin—muscle cancer	0.000131	0.000749	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—muscle cancer	0.000131	0.000749	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00013	0.000747	CcSEcCtD
Valproic Acid—Fatigue—Methotrexate—muscle cancer	0.00013	0.000746	CcSEcCtD
Valproic Acid—HDAC2—Signaling Pathways—KIDINS220—muscle cancer	0.00013	0.00114	CbGpPWpGaD
Valproic Acid—Infection—Doxorubicin—muscle cancer	0.00013	0.000744	CcSEcCtD
Valproic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000129	0.00113	CbGpPWpGaD
Valproic Acid—Pain—Methotrexate—muscle cancer	0.000129	0.00074	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—muscle cancer	0.000128	0.000734	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—muscle cancer	0.000128	0.000733	CcSEcCtD
Valproic Acid—UGT1A3—Metabolism—FH—muscle cancer	0.000128	0.00112	CbGpPWpGaD
Valproic Acid—Tachycardia—Doxorubicin—muscle cancer	0.000127	0.000731	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—muscle cancer	0.000127	0.000727	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—muscle cancer	0.000126	0.000724	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—muscle cancer	0.000124	0.000714	CcSEcCtD
Valproic Acid—Feeling abnormal—Methotrexate—muscle cancer	0.000124	0.000713	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methotrexate—muscle cancer	0.000123	0.000707	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—ENO2—muscle cancer	0.000123	0.00108	CbGpPWpGaD
Valproic Acid—Hypotension—Doxorubicin—muscle cancer	0.000122	0.0007	CcSEcCtD
Valproic Acid—Urticaria—Methotrexate—muscle cancer	0.00012	0.000687	CcSEcCtD
Valproic Acid—Abdominal pain—Methotrexate—muscle cancer	0.000119	0.000684	CcSEcCtD
Valproic Acid—Body temperature increased—Methotrexate—muscle cancer	0.000119	0.000684	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000119	0.000682	CcSEcCtD
Valproic Acid—HDAC2—Cell Cycle—TP53—muscle cancer	0.000119	0.00104	CbGpPWpGaD
Valproic Acid—Insomnia—Doxorubicin—muscle cancer	0.000118	0.000677	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—PTCH1—muscle cancer	0.000118	0.00104	CbGpPWpGaD
Valproic Acid—Paraesthesia—Doxorubicin—muscle cancer	0.000117	0.000672	CcSEcCtD
Valproic Acid—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000117	0.00103	CbGpPWpGaD
Valproic Acid—Dyspnoea—Doxorubicin—muscle cancer	0.000116	0.000668	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—muscle cancer	0.000116	0.000666	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—KIT—muscle cancer	0.000115	0.00101	CbGpPWpGaD
Valproic Acid—Dyspepsia—Doxorubicin—muscle cancer	0.000115	0.000659	CcSEcCtD
Valproic Acid—SLC16A1—Hemostasis—IGF2—muscle cancer	0.000114	0.001	CbGpPWpGaD
Valproic Acid—Decreased appetite—Doxorubicin—muscle cancer	0.000114	0.000651	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000113	0.000646	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—muscle cancer	0.000113	0.00099	CbGpPWpGaD
Valproic Acid—Fatigue—Doxorubicin—muscle cancer	0.000113	0.000646	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—MED12—muscle cancer	0.000113	0.000988	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000112	0.000984	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—FH—muscle cancer	0.000112	0.000981	CbGpPWpGaD
Valproic Acid—Constipation—Doxorubicin—muscle cancer	0.000112	0.00064	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—muscle cancer	0.000112	0.00064	CcSEcCtD
Valproic Acid—Hypersensitivity—Methotrexate—muscle cancer	0.000111	0.000637	CcSEcCtD
Valproic Acid—UGT2B7—Metabolism—FH—muscle cancer	0.000109	0.000954	CbGpPWpGaD
Valproic Acid—Asthenia—Methotrexate—muscle cancer	0.000108	0.00062	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—muscle cancer	0.000108	0.000617	CcSEcCtD
Valproic Acid—HDAC9—Disease—FOXO1—muscle cancer	0.000107	0.00094	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000107	0.000612	CcSEcCtD
Valproic Acid—Pruritus—Methotrexate—muscle cancer	0.000107	0.000612	CcSEcCtD
Valproic Acid—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000107	0.000937	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IGF2—muscle cancer	0.000104	0.000915	CbGpPWpGaD
Valproic Acid—Urticaria—Doxorubicin—muscle cancer	0.000104	0.000595	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—muscle cancer	0.000103	0.000592	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—muscle cancer	0.000103	0.000592	CcSEcCtD
Valproic Acid—Diarrhoea—Methotrexate—muscle cancer	0.000103	0.000592	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—ENO2—muscle cancer	0.000103	0.000901	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FOXO4—muscle cancer	0.000101	0.000891	CbGpPWpGaD
Valproic Acid—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	0.000101	0.000888	CbGpPWpGaD
Valproic Acid—Dizziness—Methotrexate—muscle cancer	9.97e-05	0.000572	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—CNR1—muscle cancer	9.96e-05	0.000875	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	9.74e-05	0.000856	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Doxorubicin—muscle cancer	9.62e-05	0.000552	CcSEcCtD
Valproic Acid—Vomiting—Methotrexate—muscle cancer	9.59e-05	0.00055	CcSEcCtD
Valproic Acid—Rash—Methotrexate—muscle cancer	9.51e-05	0.000545	CcSEcCtD
Valproic Acid—Dermatitis—Methotrexate—muscle cancer	9.5e-05	0.000545	CcSEcCtD
Valproic Acid—Headache—Methotrexate—muscle cancer	9.45e-05	0.000542	CcSEcCtD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—muscle cancer	9.44e-05	0.000829	CbGpPWpGaD
Valproic Acid—Asthenia—Doxorubicin—muscle cancer	9.37e-05	0.000537	CcSEcCtD
Valproic Acid—ACADSB—Metabolism—PTGS2—muscle cancer	9.32e-05	0.000819	CbGpPWpGaD
Valproic Acid—Pruritus—Doxorubicin—muscle cancer	9.24e-05	0.00053	CcSEcCtD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—muscle cancer	9.23e-05	0.00081	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.13e-05	0.000802	CbGpPWpGaD
Valproic Acid—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	9.12e-05	0.000801	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MED12—muscle cancer	9.11e-05	0.0008	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—MDM2—muscle cancer	9.08e-05	0.000798	CbGpPWpGaD
Valproic Acid—Nausea—Methotrexate—muscle cancer	8.96e-05	0.000514	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—muscle cancer	8.94e-05	0.000512	CcSEcCtD
Valproic Acid—UGT1A9—Metabolism—FH—muscle cancer	8.83e-05	0.000776	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—MED12—muscle cancer	8.69e-05	0.000763	CbGpPWpGaD
Valproic Acid—Dizziness—Doxorubicin—muscle cancer	8.64e-05	0.000495	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—muscle cancer	8.3e-05	0.000476	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—muscle cancer	8.23e-05	0.000472	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—muscle cancer	8.23e-05	0.000472	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—muscle cancer	8.18e-05	0.000469	CcSEcCtD
Valproic Acid—HDAC9—Disease—KIT—muscle cancer	8.16e-05	0.000716	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IGF2—muscle cancer	8.14e-05	0.000715	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PTGS2—muscle cancer	7.93e-05	0.000696	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ENO2—muscle cancer	7.92e-05	0.000696	CbGpPWpGaD
Valproic Acid—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	7.8e-05	0.000685	CbGpPWpGaD
Valproic Acid—Nausea—Doxorubicin—muscle cancer	7.76e-05	0.000445	CcSEcCtD
Valproic Acid—SLC16A1—Metabolism—MED12—muscle cancer	7.74e-05	0.00068	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ENO2—muscle cancer	7.71e-05	0.000677	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	7.68e-05	0.000674	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FOXO1—muscle cancer	7.5e-05	0.000658	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—MED12—muscle cancer	7.22e-05	0.000634	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—FH—muscle cancer	7.2e-05	0.000632	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ENO2—muscle cancer	7.06e-05	0.00062	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HMGA1—muscle cancer	7.01e-05	0.000615	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—muscle cancer	6.91e-05	0.000607	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—FH—muscle cancer	6.81e-05	0.000598	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ENO2—muscle cancer	6.58e-05	0.000578	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MDM2—muscle cancer	6.42e-05	0.000564	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—MED12—muscle cancer	6.31e-05	0.000554	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—FOXO4—muscle cancer	6.28e-05	0.000552	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTGS2—muscle cancer	6.19e-05	0.000544	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—MED12—muscle cancer	6.14e-05	0.000539	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.9e-05	0.000518	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ENO2—muscle cancer	5.75e-05	0.000505	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KIT—muscle cancer	5.71e-05	0.000502	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ENO2—muscle cancer	5.6e-05	0.000492	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—FH—muscle cancer	5.49e-05	0.000482	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—FH—muscle cancer	5.37e-05	0.000472	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.27e-05	0.000463	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTCH1—muscle cancer	5.12e-05	0.00045	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—MED12—muscle cancer	4.99e-05	0.000438	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTGS2—muscle cancer	4.9e-05	0.00043	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.8e-05	0.000422	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VEGFA—muscle cancer	4.78e-05	0.00042	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—FH—muscle cancer	4.65e-05	0.000408	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—FOXO1—muscle cancer	4.64e-05	0.000408	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ENO2—muscle cancer	4.55e-05	0.0004	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MDM2—muscle cancer	4.5e-05	0.000395	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FOXO4—muscle cancer	4.4e-05	0.000387	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VEGFA—muscle cancer	4.37e-05	0.000384	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CNR1—muscle cancer	4.32e-05	0.000379	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—muscle cancer	4.28e-05	0.000376	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—FH—muscle cancer	4.15e-05	0.000365	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.1e-05	0.00036	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—MED12—muscle cancer	4.07e-05	0.000357	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MED12—muscle cancer	3.85e-05	0.000338	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—FH—muscle cancer	3.78e-05	0.000332	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ENO2—muscle cancer	3.71e-05	0.000326	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—muscle cancer	3.61e-05	0.000317	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—muscle cancer	3.57e-05	0.000314	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.56e-05	0.000312	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KIT—muscle cancer	3.54e-05	0.000311	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IGF2—muscle cancer	3.53e-05	0.00031	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ENO2—muscle cancer	3.51e-05	0.000308	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—muscle cancer	3.42e-05	0.0003	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—muscle cancer	3.3e-05	0.00029	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FOXO1—muscle cancer	3.25e-05	0.000285	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—FH—muscle cancer	3.23e-05	0.000284	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MED12—muscle cancer	3.1e-05	0.000273	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MED12—muscle cancer	3.03e-05	0.000266	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.9e-05	0.000255	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ENO2—muscle cancer	2.83e-05	0.000249	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MDM2—muscle cancer	2.79e-05	0.000245	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ENO2—muscle cancer	2.77e-05	0.000243	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—muscle cancer	2.76e-05	0.000242	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—muscle cancer	2.69e-05	0.000236	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MED12—muscle cancer	2.63e-05	0.000231	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—muscle cancer	2.58e-05	0.000227	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FH—muscle cancer	2.5e-05	0.000219	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KIT—muscle cancer	2.48e-05	0.000218	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—muscle cancer	2.46e-05	0.000216	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ENO2—muscle cancer	2.4e-05	0.00021	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MED12—muscle cancer	2.35e-05	0.000206	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—muscle cancer	2.29e-05	0.000201	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MED12—muscle cancer	2.14e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ENO2—muscle cancer	2.14e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—muscle cancer	2e-05	0.000176	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MDM2—muscle cancer	1.95e-05	0.000171	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—muscle cancer	1.95e-05	0.000171	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ENO2—muscle cancer	1.95e-05	0.000171	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.87e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MED12—muscle cancer	1.83e-05	0.00016	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.67e-05	0.000147	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—muscle cancer	1.67e-05	0.000146	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—muscle cancer	1.58e-05	0.000139	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.52e-05	0.000134	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—muscle cancer	1.48e-05	0.00013	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MED12—muscle cancer	1.41e-05	0.000124	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.3e-05	0.000114	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—muscle cancer	1.29e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—muscle cancer	1.29e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—muscle cancer	1.22e-05	0.000107	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—muscle cancer	1.12e-05	9.83e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—muscle cancer	9.85e-06	8.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—muscle cancer	9.63e-06	8.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—muscle cancer	8.34e-06	7.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—muscle cancer	7.45e-06	6.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—muscle cancer	6.79e-06	5.96e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—muscle cancer	5.8e-06	5.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—muscle cancer	4.48e-06	3.93e-05	CbGpPWpGaD
